NCT04238819 2026-03-02A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaEli Lilly and CompanyPhase 1/2 Completed47 enrolled 36 charts
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled
NCT00089245 2023-12-26Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerY-mAbs TherapeuticsPhase 1 Terminated177 enrolled